Authors say findings support guidance to avoid these medications when possible
Deterioration seen for mortality and across a range of chronic physical, developmental, and mental health conditions
System uses plain lumbar anteroposterior X-ray image
89 percent of 509 patients would have been ineligible for MajesTEC-1 trial; estimated median PFS was 5.8 months
Optimistic expectations in adults with asthma tied to clinical improvements, and negative expectations tied to worsening symptoms over time
Association between plant-based diet and IBD risk was mediated by neutrophils, white blood cells, and C-reactive protein
Better control of nocturnal blood pressure and improved circadian rhythm seen with bedtime versus daytime dosing
Incidence of otitis media with effusion significantly lower for patients with unilateral cleft lip and palate undergoing velar adhesion
Model demonstrated strong diagnostic performance, outperforming clinical diagnostic model in validation cohort
No significant difference in accuracy seen between SPAT using ≥4.5-mm cutoff and SPT for birch, house dust mite allergy
Association between AD and increased risk for chronic kidney disease seen for men and women and in all age groups
No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder
7-hydroxymitragynine is not approved for use as dietary supplement, food additive, or drug ingredient
Significant sex interaction observed, with stronger associations in the female group
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss